Blood Pressure Alterations in CML Patients Treated with Imatinib vs. Nilotinib : A Clinical Insight
Authors
Wardiyanti Anwar
Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Indonesia
Tutik Harjianti
Hematology and Clinical Oncology Division, Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Indonesia
Pendrik Tandean
Cardiovascular Division, Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Indonesia
Syakib Bakri
Nephrology and Hypertension Division, Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Indonesia
Faridin Hp
Rheumatology Division, Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Indonesia
Andi Alfian Zainuddin
Department of Public Health, Faculty of Medicine, Hasanuddin University, Indonesia
Language: English
Submitted on: Feb 19, 2026
Published on: Apr 6, 2026
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Wardiyanti Anwar, Tutik Harjianti, Pendrik Tandean, Syakib Bakri, Faridin Hp, Andi Alfian Zainuddin, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.